Use of serum markers of tumor burden and bone resorption to monitor disease progression in a nude mouse model of breast cancer-induced osteolysis.

被引：0
|
作者：
NicAmhlaoibh, R
Risteli, J
Holst-Hansen, C
Qvist, P
Christiansen, C
Brünner, N
Delaissé, J
Heegaard, A
机构：
[1] Univ Oulu, Dept Clin Chem, Oulu, Finland
[2] Nord Biosci AS, Herlev, Denmark
[3] CCBR, Ballerup, Denmark
[4] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU78
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 43 条
  • [21] Role of p38 MAPK in bone pain and disease progression in a murine model of osteolytic/osteoblastic cancer-induced bone pain
    Sukhtankar, D. D.
    Okun, A.
    Chandramouli, A.
    Nelson, M.
    Vanderah, T. W.
    Porreca, F.
    King, T.
    BONE, 2010, 47 : S286 - S286
  • [22] Prevention of tumor growth and tumor-induced osteolysis by the RANKL inhibitor osteoprotegerin (OPG) is associated with significant improvement in survival using a mouse model of breast cancer bone metastasis
    Canon, J.
    Roudier, M.
    Bryant, R.
    Radinsky, R.
    Dougall, W.
    BONE, 2007, 40 (06) : S145 - S145
  • [23] Apo2L/TRAIL is a potent anticancer agent that prevents breast cancer-induced bone destruction in a mouse model
    Evdokiou, A
    Minh, LT
    Labrinidis, A
    Hay, S
    Liapis, V
    Bouralexis, S
    Welldon, K
    Butler, L
    Findlay, DM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P35 - P35
  • [24] ZK-EPO, a third-generation epothilone inhibits tumor growth and osteolysis in a mouse model of breast cancer bone metastasis
    Kakonen, S.
    Hoffmann, J.
    Klar, U.
    ANNALS OF ONCOLOGY, 2007, 18 : 35 - 35
  • [25] Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis
    Jude R. Canon
    Martine Roudier
    Rebecca Bryant
    Sean Morony
    Marina Stolina
    Paul J. Kostenuik
    William C. Dougall
    Clinical & Experimental Metastasis, 2008, 25 : 119 - 129
  • [26] Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis
    Canon, Jude R.
    Roudier, Martine
    Bryant, Rebecca
    Morony, Sean
    Stolina, Marina
    Kostenuik, Paul J.
    Dougall, William C.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (02) : 119 - 129
  • [27] A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain
    Edwards, Katie A.
    Havelin, Joshua J.
    Mcintosh, Mary I.
    Ciccone, Haley A.
    Pangilinan, Kathlene
    Imbert, Ian
    Largent-Milnes, Tally M.
    King, Tamara
    Vanderah, Todd W.
    Streicher, John M.
    JOURNAL OF PAIN, 2018, 19 (06): : 612 - 625
  • [28] Apo2L/TRAIL is a potent anti-cancer agent that prevents breast cancer-induced bone destruction in a mouse model
    Evdokiou, A
    Findlay, DM
    Minh, TL
    Labrinidis, A
    Hay, S
    Liapis, V
    Bouralexis, S
    Welldon, K
    BONE, 2005, 36 : S144 - S144
  • [29] Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis
    Logan, John G.
    Sophocleous, Antonia
    Marino, Silvia
    Muir, Morwenna
    Brunton, Valerie G.
    Idris, Aymen I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (05) : 1229 - 1242
  • [30] Quantitative Image Analysis Method for Measuring Whole-body Tumor Burden in a Mouse Model of Breast Cancer Bone Metastasis
    Kaekoenen, R. S.
    Rissanen, J. P.
    Suominen, M. I.
    Halleen, J. N.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S187 - S187
12345